Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge.
D000498:Allyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D000814:Aniline Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D006084:Graft Rejection; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000276:immunology; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D010954:Plasmacytoma / Q000188:drug therapy* / Q000276:immunology; D014184:Transplantation, Homologous; D014508:Urea / Q000008:administration & dosage / Q000627:therapeutic use*
D000498:Allyl Compounds; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D003520:Cyclophosphamide; D014508:Urea; D005472:Fluorouracil